News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
95,051 Results
Type
Article (4511)
Company Profile (21)
Press Release (90519)
Multimedia
Podcasts (5)
Webinars (2)
Section
Business (24856)
Career Advice (135)
Deals (5340)
Drug Delivery (9)
Drug Development (13204)
Employer Resources (14)
FDA (2897)
Job Trends (1799)
News (45972)
Policy (3585)
Tag
Academia (449)
Accelerated approval (2)
Adcomms (4)
Allergies (11)
Alliances (7277)
ALS (57)
Alzheimer's disease (599)
Antibody-drug conjugate (ADC) (15)
Approvals (2904)
Artificial intelligence (59)
Autoimmune disease (4)
Automation (2)
Bankruptcy (40)
Best Places to Work (1629)
BIOSECURE Act (1)
Biosimilars (7)
Biotechnology (18)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (19)
Cancer (274)
Cardiovascular disease (20)
Career advice (99)
CAR-T (30)
Cell therapy (97)
Cervical cancer (1)
Clinical research (10897)
Collaboration (174)
Compensation (53)
Complete response letters (2)
COVID-19 (235)
CRISPR (6)
C-suite (26)
Cystic fibrosis (17)
Data (473)
Denatured (2)
Depression (11)
Diabetes (30)
Diagnostics (836)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (26)
Drug pricing (8)
Duchenne muscular dystrophy (38)
Earnings (10338)
Editorial (5)
Employer branding (3)
Employer resources (12)
Events (13432)
Executive appointments (102)
FDA (3199)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (128)
Gene editing (17)
Generative AI (5)
Gene therapy (73)
GLP-1 (54)
Government (334)
Guidances (33)
Healthcare (2539)
Huntington's disease (9)
IgA nephropathy (3)
Immunology and inflammation (19)
Indications (4)
Infectious disease (246)
Inflammatory bowel disease (16)
Inflation Reduction Act (1)
Influenza (2)
Intellectual property (18)
Interviews (13)
IPO (2523)
IRA (2)
Job creations (243)
Job search strategy (84)
Labor market (1)
Layoffs (36)
Legal (534)
Liver cancer (6)
Lung cancer (31)
Lymphoma (35)
Machine learning (2)
Management (3)
Manufacturing (33)
MASH (7)
Medical device (2060)
Medtech (2061)
Mergers & acquisitions (2961)
Metabolic disorders (60)
Multiple sclerosis (53)
NASH (1)
Neurodegenerative disease (41)
Neuropsychiatric disorders (11)
Neuroscience (902)
NextGen: Class of 2025 (832)
Non-profit (455)
Now hiring (3)
Obesity (23)
Opinion (27)
Ovarian cancer (6)
Pain (16)
Pancreatic cancer (6)
Parkinson's disease (99)
Partnered (2)
Patents (48)
Patient recruitment (21)
Peanut (5)
People (6396)
Pharmaceutical (12)
Pharmacy benefit managers (1)
Phase I (2964)
Phase II (4820)
Phase III (3953)
Pipeline (284)
Policy (8)
Postmarket research (437)
Preclinical (1309)
Press Release (1)
Prostate cancer (11)
Psychedelics (9)
Radiopharmaceuticals (30)
Rare diseases (92)
Real estate (577)
Recruiting (5)
Regulatory (3064)
Reports (5)
Research institute (355)
Resumes & cover letters (43)
Rett syndrome (6)
RNA editing (3)
RSV (1)
Schizophrenia (23)
Series A (20)
Series B (15)
Sickle cell disease (11)
Special edition (3)
Spinal muscular atrophy (79)
Sponsored (4)
Startups (419)
Stomach cancer (1)
Supply chain (5)
Tariffs (1)
The Weekly (3)
Vaccines (45)
Venture capitalists (3)
Weight loss (7)
Women's health (3)
Date
Today (41)
Last 7 days (172)
Last 30 days (555)
Last 365 days (5833)
2025 (2146)
2024 (6226)
2023 (6579)
2022 (8691)
2021 (9207)
2020 (7705)
2019 (6166)
2018 (4835)
2017 (4680)
2016 (4276)
2015 (5185)
2014 (3475)
2013 (2779)
2012 (3259)
2011 (3449)
2010 (3095)
Location
Africa (66)
Alabama (28)
Alaska (2)
Arizona (25)
Arkansas (2)
Asia (4781)
Australia (905)
California (1057)
Canada (438)
China (72)
Colorado (40)
Connecticut (62)
Delaware (32)
Europe (11254)
Florida (186)
Georgia (19)
Idaho (5)
Illinois (82)
India (1)
Indiana (36)
Iowa (1)
Japan (56)
Kansas (35)
Kentucky (5)
Louisiana (5)
Maine (7)
Maryland (136)
Massachusetts (1016)
Michigan (13)
Minnesota (69)
Missouri (11)
Nebraska (3)
Nevada (23)
New Hampshire (16)
New Jersey (353)
New Mexico (6)
New York (415)
North Carolina (68)
North Dakota (3)
Northern California (528)
Ohio (33)
Oregon (3)
Pennsylvania (208)
Rhode Island (4)
South America (90)
South Carolina (2)
Southern California (389)
Tennessee (12)
Texas (171)
United States (4198)
Utah (32)
Virginia (11)
Washington D.C. (4)
Washington State (93)
Wisconsin (13)
95,051 Results for "natus neurology incorporated".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Natus to showcase game-changing innovations at Neurocritical Care Society Conference
October 15, 2024
·
2 min read
BioMidwest
Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS
Natus Medical Incorporated announced the closing of its acquisition of Micromed Holding SAS, a global provider of neurophysiology solutions.
January 18, 2023
·
3 min read
Opinion
Bringing Neurological Disease Into the Age of Precision Medicine
To more effectively treat neurodegenerative conditions, we first need diagnostic tools that lend a more complete picture of protein aggregates in the brain.
May 12, 2025
·
5 min read
·
John McDonough
Deals
Natus Medical Incorporated to Acquire Micromed Holding SAS
Natus Medical Incorporated has entered into a definitive agreement to acquire Micromed Holding SAS, a global provider of neurophysiology solutions.
December 2, 2022
·
4 min read
Press Releases
UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025
April 3, 2025
·
34 min read
FDA
Natus seeks FDA 510(k) clearance for its highly anticipated point-of-care EEG solution
October 10, 2024
·
2 min read
Press Releases
Natus introduces new FDA cleared Grass® MR Conditional / CT Cup Electrodes featuring longer lead lengths
October 17, 2024
·
3 min read
Press Releases
EISAI TO PRESENT LECANEMAB REAL-WORLD EXPERIENCE DATA AND FINDINGS FROM NEUROLOGY PORTFOLIO AT THE AMERICAN ACADEMY OF NEUROLOGY (AAN) ANNUAL MEETING
March 26, 2025
·
10 min read
Press Releases
Baylor Genetics Joins Child Neurology Society as Official Genetic Testing Partner
April 29, 2025
·
3 min read
Deals
ArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity value
Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), announced today that the MED Platform II fund of ArchiMed (“ArchiMed”), a leading investment firm focused exclusively on the healthcare industry, completed the acquisition of Natus.
July 21, 2022
·
3 min read
1 of 9,506
Next
